| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.9M | — | -80.9% |
| Cost of Revenue | $1.0M | — | -7.5% |
| Gross Profit | $1.8M | — | -86.9% |
| R&D Expense | $25.8M | — | +150.7% |
| SG&A Expense | $20.3M | — | +154.8% |
| Operating Income | -$54.7M | — | -384.7% |
| Pre-tax Income | -$46.8M | — | -763.5% |
| Income Tax | -$28.5M | — | — |
| Net Income | -$18.4M | — | -238.6% |
| EPS (Basic) | -$0.05 | — | -150.0% |
| EPS (Diluted) | -$0.05 | — | -150.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $338.2M | -46.8% | +11.1% |
| Short-term Investments | $250.2M | +0.4% | — |
| Accounts Receivable | $8.9M | +461.5% | +751.1% |
| Inventory | $2.9M | +5.0% | +71.3% |
| Current Assets | $607.1M | -32.3% | +95.3% |
| Total Assets | $1.20B | +31.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$45.0M | — | -133.2% |
| Capital Expenditures | $1.1M | — | +146.8% |
| Investing Cash Flow | -$252.1M | — | — |
| Financing Cash Flow | -$143K | — | -100.1% |
| Free Cash Flow | -$46.0M | — | -133.5% |
| +268.5% |
| Current Liabilities | $28.4M | +34.1% | +89.1% |
| Long-term Debt | $35.4M | -1.1% | +16.6% |
| Total Liabilities | $75.6M | +18.8% | -36.1% |
| Stockholders' Equity | $1.12B | +31.9% | +442.1% |